NCT05133453View on ClinicalTrials.gov

Pirfenidone Use in Asbestosis Patients: Efficacy and Prognosis

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2026

Conditions
Asbestosis
Interventions
DRUG

Pirfenidone

drug intake three times daily for one year

All Listed Sponsors
lead

Cairo University

OTHER

NCT05133453 - Pirfenidone Use in Asbestosis Patients: Efficacy and Prognosis | Biotech Hunter | Biotech Hunter